Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

64 records found for:
Author = Melzer A
Year =

  1. Anton A, Melzer A, Wendt CH, Kunisaki KM, Dudley RA, Baldomero AK. Characterizing Tobacco Use Status among a National Cohort of Patients with COPD. Annals of the American Thoracic Society. 2025 Mar 14 DOI: 10.1513/AnnalsATS.202406-659RL.
  2. Sullivan DR, Golden SE, Schweiger L, Melzer AC, Datta S, Davis JM, Wiener RS, Slatore CG. Associations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis. MDM policy & practice. 2025 Jan 17; 10(1):23814683241309945.
  3. Schweiger L, Golden SE, Sullivan DR, Ilea I, Rice SPM, Melzer AC, Datta S, Davis JM, Slatore CG. Is Lung Cancer Screening Knowledge Associated with Patient-Centered Outcomes? A Multi-institutional Cohort Study. MDM policy & practice. 2024 Oct 17; 9(2):23814683241286884.
  4. Deepak J, Gesthalter YB, Gogineni HP, Melzer AC. Reply to Patel and LaNou: The Missing Piece: The Intersection of Pharmacist Board Certification and Tobacco Use Disorder Treatment. ATS scholar. 2024 Sep 30; 5(3):469.
  5. Golden SE, Schweiger L, Ono S, Melzer AC, Datta S, Davis J, Slatore C. "I've been really happy since I got that letter!": Longitudinal patient perspectives on lung cancer screening communication. Preventive medicine. 2024 Dec 1; 189:108142.
  6. Melzer AC, Campbell ME, Hagedorn HJ, Fu SS. Clinician Views of Proactive Tobacco Treatment Programs: A Qualitative Evaluation. Journal of general internal medicine. 2024 Aug 1; 39(11):2079-2086.
  7. Melzer AC, Begnaud A. Planting the Seeds for Lung Cancer Screening Starts With Knowledge Holders. [Editorial]. Chest. 2024 Mar 1; 165(3):488-489.
  8. Slatore CG, Hooker ER, Shull S, Golden SE, Melzer AC. Association of patient and health care organization factors with incidental nodule guidelines adherence: A multi-system observational study. Lung cancer (Amsterdam, Netherlands). 2024 Apr 1; 190:107526.
  9. Melzer AC, Reese ZA, Mascarhenas L, Clancy CB, Deepak J, Gogineni H, Gesthalter Y, Hart JL. Education for Tobacco Use Disorder Treatment: Current State, Evidence, and Unmet Needs. ATS scholar. 2023 Dec 1; 4(4):546-566.
  10. Mascarenhas L, Campbell M, Hagedorn H, Fu SS, Melzer AC. Experiences With Tobacco Dependence Treatment Training Among Respiratory Care Clinicians: A Qualitative Assessment. CHEST pulmonary. 2023 Sep 19; 1(3).
  11. Lang AE, Melzer AC, Good CB, Upson DJ. Recommendations for Addressing the Tobacco and Nicotine Use Epidemic in U.S. Military Service Members and Veterans. Annals of the American Thoracic Society. 2023 Sep 1; 20(9):1229-1232.
  12. Fu SS, Rothman AJ, Vock DM, Lindgren BR, Almirall D, Begnaud A, Melzer AC, Schertz KL, Branson M, Haynes D, Hammett P, Joseph AM. Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening: A Sequential, Multiple Assignment, Randomized Trial. JAMA Network Open. 2023 Aug 1; 6(8):e2329903.
  13. Melzer AC, Atoma B, Fabbrini AE, Campbell M, Clothier BA, Fu SS. Variation in Reporting of Incidental Findings on Initial Lung Cancer Screening and Associations With Clinician Assessment. Journal of the American College of Radiology : JACR. 2024 Jan 1; 21(1):118-127.
  14. Gundle K, Hooker ER, Golden SE, Shull S, Crothers K, Melzer AC, Slatore CG. Use of Veterans Health Administration Structured Data to Identify Patients Eligible for Lung Cancer Screening. Military medicine. 2023 Jul 22; 188(7-8):e2419-e2423.
  15. Núñez ER, Slatore CG, Tanner NT, Melzer AC, Crothers KA, Lewis JA, Fabbrini AE, Brown JK, Wiener RS. National Survey of Lung Cancer Screening Practices in Veterans Health Administration Facilities. American journal of preventive medicine. 2023 Nov 1; 65(5):901-905.
  16. Melzer AC, Hagedorn H, Nelson D, Kaplan A, Campbell M, Fu SS. Use of Information and Communication Technology among Patients with Chronic Obstructive Pulmonary Disease Who Smoke: A Mixed Methods Study. Annals of the American Thoracic Society. 2023 Mar 1; 20(3):381-389.
  17. Rebuli ME, Rose JJ, Noël A, Croft DP, Benowitz NL, Cohen AH, Goniewicz ML, Larsen BT, Leigh N, McGraw MD, Melzer AC, Penn AL, Rahman I, Upson D, Crotty Alexander LE, Ewart G, Jaspers I, Jordt SE, Kligerman S, Loughlin CE, McConnell R, Neptune ER, Nguyen TB, Pinkerton KE, Witek TJ. The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 2023 Jan 1; 20(1):1-17.
  18. Cain CH, Murray TA, Rudser KD, Rothman AJ, Melzer AC, Joseph AM, Vock DM. Design considerations and analytical framework for reliably identifying a beneficial individualized treatment rule. Contemporary clinical trials. 2022 Dec 1; 123:106951.
  19. Golden SE, Schweiger L, Melzer AC, Ono SS, Datta S, Davis JM, Slatore CG. "It's a decision I have to make": Patient perspectives on smoking and cessation after lung cancer screening decisions. Preventive medicine reports. 2022 Dec 1; 30:102014.
  20. Unger S, Golden SE, Melzer AC, Tanner N, Deepak J, Delorit M, Scott JY, Slatore CG. Study design for a proactive teachable moment tobacco treatment intervention among patients with pulmonary nodules. Contemporary clinical trials. 2022 Oct 1; 121:106908.
  21. Greer N, Bart B, Billington CJ, Diem SJ, Ensrud KE, Kaka A, Klein M, Melzer AC, Reule S, Shaukat A, Sheets K, Starks J, Vardeny O, McKenzie L, Stroebel B, Macdonald R, Sowerby K, Duan-Porter W, Wilt TJ. COVID-19 postacute care major organ damage: a systematic review. BMJ open. 2022 Aug 24; 12(8):e061245.
  22. Begnaud A, Fu SS, Lindgren B, Melzer A, Rothman AJ, Schertz K, Vock DM, Joseph AM. Latent constructs identified in older individuals who smoke cigarettes and are eligible for lung cancer screening: Factor analysis of baseline data from the PLUTO smoking cessation trial. Contemporary clinical trials communications. 2022 Oct 1; 29:100977.
  23. Hedstrom GH, Hooker ER, Howard M, Shull S, Golden SE, Deffebach ME, Gorman JD, Murphy K, Fabbrini A, Melzer AC, Slatore CG. The Chain of Adherence for Incidentally Detected Pulmonary Nodules after an Initial Radiologic Imaging Study: A Multisystem Observational Study. Annals of the American Thoracic Society. 2022 Aug 1; 19(8):1379-1389.
  24. Melzer AC, Triplette M. Screening high risk populations for lung cancer. BMJ (Clinical research ed.). 2022 Mar 30; 376:o666.
  25. Eakin MN, Bauer SE, Carr T, Dagli E, Ewart G, Garfield JL, Jaspers I, Kher S, Leone FT, Melzer AC, Moazed F, Moraes TJ, Reddy KP, Upson D, Kathuria H. Policy Recommendations to Eliminate Tobacco Use and Improve Health from the American Thoracic Society Tobacco Action Committee. Annals of the American Thoracic Society. 2022 Feb 1; 19(2):157-160.
  26. Greer NL, Bart BA, Billington C, Diem SJ, Ensrud KE, Kaka A, Klein M, Melzer AC, Reule S, Shaukat A, Sheets K, Starks J, Ni OV, McKenzie L, Stroebel B, MacDonald R, Sowerby K, Duan-Porter WD, Wilt TJ. COVID-19 Post-acute Care Major Organ Damage: A Living Rapid Review. Health Services Research and Development Service. Washington DC: Evidence Synthesis Program (ESP) Center; 2021 Sep 1. 1-196 p. Report No.: ESP Project #09-009.
  27. Melzer AC, Begnaud A, Lindgren BR, Schertz K, Fu SS, Vock DM, Rothman AJ, Joseph AM. Self-reported exercise capacity among current smokers eligible for lung cancer screening: Distribution and association with key comorbidities. Cancer treatment and research communications. 2021 Jul 31; 28:100443.
  28. Slatore CG, Melzer A. Lung Cancer Screening is a Process, Not a Scan. American Cancer Society's TheoryLab on Apple Podcasts [Internet]. 2021 May 17: Available from: https://podcasts.apple.com/us/podcast/lung-cancer-screening-is-a-process-not-a-scan/id1454395139?i=1000522034736.
  29. Baldomero AK, Melzer AC, Greer N, Majeski BN, MacDonald R, Linskens EJ, Wilt TJ. Effectiveness and Harms of High-Flow Nasal Oxygen for Acute Respiratory Failure: An Evidence Report for a Clinical Guideline From the American College of Physicians. Annals of internal medicine. 2021 Jul 1; 174(7):952-966.
  30. Hegland AJ, Bolduc J, Jones L, Kunisaki KM, Melzer AC. Pharmacist-Driven Deprescribing of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 2021 Apr 1; 18(4):730-733.
  31. Shen J, Crothers K, Kross EK, Petersen K, Melzer AC, Triplette M. Provision of Smoking Cessation Resources in the Context of In-Person Shared Decision-Making for Lung Cancer Screening. Chest. 2021 Aug 1; 160(2):765-775.
  32. Melzer AC, Wilt TJ. Expanded Access to Lung Cancer Screening-Implementing Wisely to Optimize Health. JAMA Network Open. 2021 Mar 1; 4(3):e210275.
  33. Galiatsatos P, Garfield J, Melzer AC, Leone FT, Farber HJ, Ruminjo JK, Thomson CC. Summary for Clinicians: An ATS Clinical Practice Guideline for Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. Annals of the American Thoracic Society. 2021 Feb 1; 18(2):187-190.
  34. Fu SS, Melzer AC. Helping Patients to Quit Smoking: New Approaches Needed. Chest. 2020 Nov 1; 158(5):1822-1823.
  35. Melzer AC, Iaccarino JM. Standardized Reporting and Management of Pulmonary Nodules: Integrating Care to Improve Outcomes. Chest. 2020 Nov 1; 158(5):1824-1826.
  36. Schweiger L, Tostado PR, Golden SE, Melzer AC, Datta S, Sullivan DR, Slatore CG. Lung Cancer Screening: Association of Lung Cancer Susceptibility and Risk with Decisional Conflict and Distress. [Abstract]. American journal of respiratory and critical care medicine. 2020 Nov 1; 201(C30):A4728.
  37. Japuntich SJ, Hammett PJ, Rogers ES, Fu S, Burgess DJ, El Shahawy O, Melzer AC, Noorbaloochi S, Krebs P, Sherman SE. Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2020 Aug 24; 22(9):1433-1438.
  38. Melzer AC, Golden SE, Ono SS, Datta S, Triplette M, Slatore CG. "We Just Never Have Enough Time": Clinician Views of Lung Cancer Screening Processes and Implementation. Annals of the American Thoracic Society. 2020 Jun 4.
  39. Golden SE, Ono SS, Melzer A, Davis J, Zeliadt SB, Heffner JL, Kathuria H, Garcia-Alexander G, Slatore CG. "I Already Know That Smoking Ain't Good for Me": Patient and Clinician Perspectives on Lung Cancer Screening Decision-Making Discussions as a Teachable Moment. Chest. 2020 Sep 1; 158(3):1250-1259.
  40. Golden SE, Ono SS, Thakurta SG, Wiener RS, Iaccarino JM, Melzer AC, Datta SK, Slatore CG. "I'm Putting My Trust in Their Hands": A Qualitative Study of Patients' Views on Clinician Initial Communication About Lung Cancer Screening. Chest. 2020 Sep 1; 158(3):1260-1267.
  41. Lee C, Wongjarupong N, Narayan M, Melzer AC. Acute Cholecystitis Complicated with Gallbladder Perforation and Peritonitis Caused by Vancomycin-resistant Lactobacillus paracasei. Cureus. 2020 Mar 30; 12(3):e7476.
  42. Baldomero AK, Melzer A, Greer N, Majeski BN, Macdonald R, Wilt TJ. Effectiveness and harms of high-flow nasal oxygen (HFNO) for acute respiratory failure: a systematic review protocol. BMJ open. 2020 Feb 12; 10(2):e034956.
  43. Aase A, Fabbrini AE, White KM, Averill S, Gravely A, Melzer AC. Implementation of a Standardized Template for Reporting of Incidental Pulmonary Nodules: Feasibility, Acceptability, and Outcomes. Journal of the American College of Radiology : JACR. 2020 Feb 1; 17(2):216-223.
  44. Melzer AC, Golden SE, Ono SS, Datta S, Crothers K, Slatore CG. What Exactly Is Shared Decision-Making? A Qualitative Study of Shared Decision-Making in Lung Cancer Screening. Journal of general internal medicine. 2020 Feb 1; 35(2):546-553.
  45. Fu SS, Melzer AC, Fabbrini AE, Rice KL, Clothier B, Nelson DB, Doro EA, Partin MR. Association of invitation to lung cancer screening and tobacco use outcomes in a VA demonstration project. Preventive medicine reports. 2019 Dec 1; 16:101023.
  46. Begnaud A, Yang P, Robichaux C, Rubin N, Kratzke R, Melzer A, Aliferis C, Jacobson P. Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities. Clinical lung cancer. 2020 May 1; 21(3):e164-e168.
  47. Melzer AC, Fabbrini A, Rice KL, Clothier BA, Bangerter AK, Fu SS. Frequency, Significance, and Outcome of Incidental Findings Identified on Initial Lung Cancer Screening Exams. [Abstract]. American journal of respiratory and critical care medicine. 2019 May 21; 199(A4486):https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A4486.
  48. Melzer AC, Aase A, Fabbrini A, Averill S, White K. Implementation of a Standardized Template for Reporting of Incidental Pulmonary Nodules: A Mixed Methods Study. [Abstract]. American journal of respiratory and critical care medicine. 2019 May 20; 199(A3053):https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A3053.
  49. Melzer AC, Golden SE, Wiener RS, Iaccarino JM, Slatore CG. A Brief Report of Smoking Behaviors in Patients with Incidental Pulmonary Nodules: Associations with Communication and Risk Perception. Tobacco use insights. 2019 Apr 15; 12:1179173X19839059.
  50. MacDonald DM, Melzer AC, Collins G, Avihingsanon A, Crothers K, Ingraham NE, Mugerwa H, Ristola M, Shuter J, Kunisaki KM, INSIGHT START Pulmonary Substudy Group. Smoking and Accelerated Lung Function Decline in HIV-Positive Individuals: A Secondary Analysis of the START Pulmonary Substudy. Journal of acquired immune deficiency syndromes (1999). 2018 Nov 1; 79(3):e85-e92.
  51. Melzer AC, Pinsker EA, Clothier B, Noorbaloochi S, Burgess DJ, Danan ER, Fu SS. Validating the use of veterans affairs tobacco health factors for assessing change in smoking status: accuracy, availability, and approach. BMC medical research methodology. 2018 May 11; 18(1):39.
  52. Melzer AC, Clothier BA, Japuntich SJ, Noorbaloochi S, Hammett P, Burgess DJ, Joseph AM, Fu SS. Comparative Effectiveness of Proactive Tobacco Treatment among Smokers with and without Chronic Lower Respiratory Disease. Annals of the American Thoracic Society. 2018 Mar 1; 15(3):341-347.
  53. Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM. Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. American journal of respiratory and critical care medicine. 2018 Jan 15; 197(2):172-182.
  54. Lillie SE, Fu SS, Fabbrini AE, Rice KL, Clothier BA, Doro E, Melzer AC, Partin MR. Does need for cognitive closure explain individual differences in lung cancer screening? A brief report. Journal of Health Psychology. 2020 Jul 1; 25(8):1109-1117.
  55. Miranda LS, Datta S, Melzer AC, Wiener RS, Davis JM, Tong BC, Golden SE, Slatore CG. Rationale and Design of the Lung Cancer Screening Implementation. Evaluation of Patient-Centered Care Study. Annals of the American Thoracic Society. 2017 Oct 1; 14(10):1581-1590.
  56. Fu SS, Rothman AJ, Vock DM, Lindgren B, Almirall D, Begnaud A, Melzer A, Schertz K, Glaeser S, Hammett P, Joseph AM. Program for lung cancer screening and tobacco cessation: Study protocol of a sequential, multiple assignment, randomized trial. Contemporary clinical trials. 2017 Sep 1; 60:86-95.
  57. Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Vollmer WM, Au DH. Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respiratory medicine. 2017 Feb 1; 123:124-130.
  58. Melzer AC, Feemster LC, Crothers K, Carson SS, Gillespie SE, Henderson AG, Krishnan JA, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Pickard AS, Au DH, COPD Outcomes-based Network for Clinical Effectiveness and Research Translation Consortium. Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 2016 Sep 1; 13(9):1490-6.
  59. Melzer AC, Feemster LC, Collins MP, Au DH. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD. Journal of hospital medicine. 2016 Apr 1; 11(4):257-63.
  60. Melzer AC, Feemster LC, Collins MP, Au DH. Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes. Journal of general internal medicine. 2016 Jun 1; 31(6):623-9.
  61. Melzer AC, Uman J, Au DH. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation. Annals of the American Thoracic Society. 2015 Jun 1; 12(6):831-7.
  62. Melzer AC, Au DH. Effectiveness of Post-Discharge Smoking Cessation Management Following Exacerbation of COPD. Paper presented at: American Thoracic Society Annual International Conference; 2015 May 20; Denver, CO.
  63. Melzer AC, Uman J, Au DH. Predictors Of Decreased Medication Adherence For Hypertensive Patients. Poster session presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  64. Melzer AC, Feemster LM, Uman JE, Ramenofsky DH, Au DH. Missing potential opportunities to reduce repeat COPD exacerbations. Journal of general internal medicine. 2013 May 1; 28(5):652-9.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.